• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品:其在临床实践中应用的定义及流行病学依据。

Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice.

作者信息

Volpe Roberto, Sotis Gianluca

机构信息

Italian National Research Council, Rome, Italy,

出版信息

High Blood Press Cardiovasc Prev. 2015 Sep;22(3):199-201. doi: 10.1007/s40292-015-0092-5. Epub 2015 May 1.

DOI:10.1007/s40292-015-0092-5
PMID:25929684
Abstract

Cardiometabolic risk factors, such as hypercholesterolemia, hypertriglyceridemia, metabolic syndrome, diabetes, and arterial hypertension, are major predictors of the premature development of cardiovascular diseases (CVD). Since CVD prevention needs a life-course approach, beyond dietary and pharmacological treatment, non-pharmacological treatment should be considered an important alternative for patients in primary prevention with mild-moderate cardiometabolic risk factors at low-moderate global risk of CVD. Several functional foods and nutraceuticals are efficacious, safe and well tolerated. However, only some (monacolins of red yeast rice and omega-3 fatty acids) have showed, in long-term randomized clinical trials, a reduction of cardiovascular events.

摘要

心血管代谢危险因素,如高胆固醇血症、高甘油三酯血症、代谢综合征、糖尿病和动脉高血压,是心血管疾病(CVD)过早发生的主要预测因素。由于心血管疾病的预防需要采取贯穿一生的方法,除了饮食和药物治疗外,非药物治疗应被视为对心血管疾病全球风险处于低至中度、具有轻度至中度心血管代谢危险因素的一级预防患者的重要替代方案。几种功能性食品和营养保健品有效、安全且耐受性良好。然而,只有一些(红曲米中的莫纳可林和ω-3脂肪酸)在长期随机临床试验中显示可减少心血管事件。

相似文献

1
Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice.营养保健品:其在临床实践中应用的定义及流行病学依据。
High Blood Press Cardiovasc Prev. 2015 Sep;22(3):199-201. doi: 10.1007/s40292-015-0092-5. Epub 2015 May 1.
2
Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.欧米伽-3脂肪酸与心血管疾病的一级和二级预防
Cell Biochem Biophys. 2015 May;72(1):77-81. doi: 10.1007/s12013-014-0407-5.
3
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.在临床实践中测试一种降脂营养保健品的短期疗效:一项多中心研究。
J Med Food. 2015 Nov;18(11):1270-3. doi: 10.1089/jmf.2015.0024. Epub 2015 Aug 14.
4
An update on the safety of nutraceuticals and effects on lipid parameters.营养保健品安全性及其对脂质参数影响的最新进展。
Expert Opin Drug Saf. 2018 Mar;17(3):303-313. doi: 10.1080/14740338.2018.1429404. Epub 2018 Jan 29.
5
Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.具有降脂作用的常用膳食补充剂和营养保健品的耐受性和安全性。
Expert Opin Drug Saf. 2012 Sep;11(5):753-66. doi: 10.1517/14740338.2012.705827. Epub 2012 Jul 13.
6
Omega-3 Fatty Acid Supplements and Risk of CHD.欧米伽-3脂肪酸补充剂与冠心病风险
Am J Nurs. 2018 May;118(5):69. doi: 10.1097/01.NAJ.0000532837.93389.c2.
7
Vitamin D, Omega-3 Fatty Acids Don't Lower Rates of Cancer or CVD.维生素 D 和欧米伽 3 脂肪酸并不能降低癌症或心血管疾病的发病率。
Am J Nurs. 2019 Feb;119(2):15. doi: 10.1097/01.NAJ.0000553195.75599.75.
8
Management of Dyslipidemia in Individuals with Low-to-Moderate Cardiovascular Risk: Role of Nutraceuticals.低-中度心血管风险个体的血脂异常管理:营养保健品的作用。
Adv Ther. 2020 Nov;37(11):4549-4567. doi: 10.1007/s12325-020-01490-z. Epub 2020 Sep 26.
9
Omega-3 fatty acids for cardioprotection.用于心脏保护的欧米伽-3脂肪酸。
Mayo Clin Proc. 2008 Mar;83(3):324-32. doi: 10.4065/83.3.324.
10
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP).营养保健品对全身炎症标志物的影响:与心血管疾病的潜在相关性——国际脂质专家组(ILEP)的立场文件。
Prog Cardiovasc Dis. 2021 Jul-Aug;67:40-52. doi: 10.1016/j.pcad.2021.06.010. Epub 2021 Jun 27.

引用本文的文献

1
TG/HDL-c ratio as a predictor of progressive infarction in patients with anterior circulation single subcortical infarction.载脂蛋白 TG/高密度脂蛋白胆固醇比值预测前循环单发皮质下梗死患者梗死进展。
Brain Behav. 2024 Feb;14(2):e3453. doi: 10.1002/brb3.3453.
2
The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension.天然抗氧化剂对与动脉高血压相关的内皮功能障碍的潜在影响。
Front Cardiovasc Med. 2024 Feb 2;11:1345218. doi: 10.3389/fcvm.2024.1345218. eCollection 2024.
3
Benchmarking Nutraceutical Soybean Composition Relative to Protein and Oil.

本文引用的文献

1
Nutraceuticals for metabolic syndrome management: from laboratory to benchside.用于代谢综合征管理的营养保健品:从实验室到临床应用
Curr Vasc Pharmacol. 2014;12(4):565-71. doi: 10.2174/15701611113119990120.
2
Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals.有临床相关疗效证据的膳食补充剂和营养保健品。
Curr Hypertens Rep. 2013 Jun;15(3):260-7. doi: 10.1007/s11906-013-0333-8.
3
Lifestyle-related risk factors, smoking status and cardiovascular disease.与生活方式相关的风险因素、吸烟状况与心血管疾病
对标营养保健品大豆中蛋白质和油脂的成分
Front Nutr. 2021 Aug 11;8:663434. doi: 10.3389/fnut.2021.663434. eCollection 2021.
4
The Modulation of PCSK9 and LDLR by Supercritical CO Extracts of and Isolated Piperitone Oxide, an Study.超临界 CO2 萃取物及分离的胡椒酮氧化物对 PCSK9 和 LDLR 的调节作用:一项 研究。
Molecules. 2021 Jun 25;26(13):3886. doi: 10.3390/molecules26133886.
5
Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences.慢性冠状动脉综合征中的营养保健品:临床前数据与转化经验
High Blood Press Cardiovasc Prev. 2021 Jan;28(1):13-25. doi: 10.1007/s40292-020-00416-8. Epub 2020 Oct 30.
6
Commentary to "The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease".《营养保健品在预防心血管疾病中的潜在作用》述评
High Blood Press Cardiovasc Prev. 2019 Jun;26(3):259-261. doi: 10.1007/s40292-019-00317-5. Epub 2019 May 7.
7
Role of cholesterol and sphingolipids in brain development and neurological diseases.胆固醇和神经鞘脂在大脑发育和神经疾病中的作用。
Lipids Health Dis. 2019 Jan 25;18(1):26. doi: 10.1186/s12944-019-0965-z.
8
LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.一种新型膳食补充剂对 LDL 胆固醇的降低作用:一项针对轻至中度高胆固醇血症患者的开放性标签、对照、随机、交叉临床试验。
Lipids Health Dis. 2018 May 24;17(1):124. doi: 10.1186/s12944-018-0775-8.
9
Nutraceuticals: opening the debate for a regulatory framework.营养保健品:开启监管框架的辩论。
Br J Clin Pharmacol. 2018 Apr;84(4):659-672. doi: 10.1111/bcp.13496. Epub 2018 Feb 14.
10
To Nutraceuticals and Back: Rethinking a Concept.回归营养保健品:重新审视一个概念。
Foods. 2017 Sep 5;6(9):74. doi: 10.3390/foods6090074.
High Blood Press Cardiovasc Prev. 2012 Jun 1;19(2):85-92. doi: 10.1007/BF03262458.
4
Effect of a combined nutraceutical containing Orthosiphon stamineus effect on blood pressure and metabolic syndrome components in hypertensive dyslipidaemic patients: a randomized clinical trial.一种含九头狮子草的复合营养补充剂对高血压伴血脂异常患者血压和代谢综合征组分的影响:一项随机临床试验。
Complement Ther Clin Pract. 2012 Aug;18(3):190-4. doi: 10.1016/j.ctcp.2012.02.002. Epub 2012 Mar 31.
5
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.长链 ω-3 脂肪酸与心血管疾病:系统评价。
Br J Nutr. 2012 Jun;107 Suppl 2:S201-13. doi: 10.1017/S0007114512001596.
6
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).欧洲心脏病学会(ESC)和欧洲动脉粥样硬化学会(EAS)血脂异常管理指南 血脂异常管理特别工作组
Atherosclerosis. 2011 Jul;217(1):3-46. doi: 10.1016/j.atherosclerosis.2011.06.028.
7
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.更强化降低 LDL 胆固醇的疗效和安全性:来自 26 项随机试验中 170000 名参与者数据的荟萃分析。
Lancet. 2010 Nov 13;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. Epub 2010 Nov 8.
8
Nutraceuticals in diabetes and metabolic syndrome.营养保健品与糖尿病和代谢综合征。
Cardiovasc Ther. 2010 Aug;28(4):216-26. doi: 10.1111/j.1755-5922.2010.00179.x.
9
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia.营养保健品对血脂异常患者代谢综合征患病率和弗莱明翰风险评分计算值的影响。
J Hypertens. 2010 Jul;28(7):1482-7. doi: 10.1097/HJH.0b013e3283395208.
10
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.血脂康(一种红曲提取物)对既往有心肌梗死的中国人群冠状动脉事件的影响。
Am J Cardiol. 2008 Jun 15;101(12):1689-93. doi: 10.1016/j.amjcard.2008.02.056. Epub 2008 Apr 11.